Glyburide
- Product NDC
- 50090-7859
- 11-digit product format
- 500907859
- Labeler code
- 50090
- Product ID
- 50090-7859_2cbc06b0-114a-46a2-a0df-29053c86015c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Glyburide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA203379
- Marketing category
- ANDA
- Marketing start
- 2021-10-05
- Substance
- GLYBURIDE
- Active strength
- 5 mg/1
- Pharmacologic classes
- Sulfonylurea Compounds [CS], Sulfonylurea [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A203379-001 | GLYBURIDE | GLYBURIDE | 1.25MG | TABLET / ORAL | AB1 | 2019-01-04 | |
| A203379-002 | GLYBURIDE | GLYBURIDE | 2.5MG | TABLET / ORAL | AB1 | 2019-01-04 | |
| A203379-003 | GLYBURIDE | GLYBURIDE | 5MG | TABLET / ORAL | AB1 | 2019-01-04 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A203379-001 | AB1 |
| A203379-002 | AB1 |
| A203379-003 | AB1 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A203379-001 | GLYBURIDE | 1.25MG | TABLET / ORAL | AB1 | 2019-01-04 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A203379-002 | GLYBURIDE | 2.5MG | TABLET / ORAL | AB1 | 2019-01-04 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A203379-003 | GLYBURIDE | 5MG | TABLET / ORAL | AB1 | 2019-01-04 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A203379-001 | GLYBURIDE | 1.25MG | TABLET / ORAL | AB1 | 2019-01-04 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A203379-002 | GLYBURIDE | 2.5MG | TABLET / ORAL | AB1 | 2019-01-04 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A203379-003 | GLYBURIDE | 5MG | TABLET / ORAL | AB1 | 2019-01-04 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A203379-001 | GLYBURIDE | 1.25MG | TABLET / ORAL | AB1 | 2019-01-04 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A203379-002 | GLYBURIDE | 2.5MG | TABLET / ORAL | AB1 | 2019-01-04 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A203379-003 | GLYBURIDE | 5MG | TABLET / ORAL | AB1 | 2019-01-04 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A203379-001 | GLYBURIDE | 1.25MG | TABLET / ORAL | AB1 | 2019-01-04 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A203379-002 | GLYBURIDE | 2.5MG | TABLET / ORAL | AB1 | 2019-01-04 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A203379-003 | GLYBURIDE | 5MG | TABLET / ORAL | AB1 | 2019-01-04 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A203379-001 | GLYBURIDE | 1.25MG | TABLET / ORAL | AB1 | 2019-01-04 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A203379-002 | GLYBURIDE | 2.5MG | TABLET / ORAL | AB1 | 2019-01-04 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A203379-003 | GLYBURIDE | 5MG | TABLET / ORAL | AB1 | 2019-01-04 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A203379-001 | GLYBURIDE | 1.25MG | TABLET / ORAL | AB1 | 2019-01-04 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A203379-002 | GLYBURIDE | 2.5MG | TABLET / ORAL | AB1 | 2019-01-04 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A203379-003 | GLYBURIDE | 5MG | TABLET / ORAL | AB1 | 2019-01-04 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A203379-001 | GLYBURIDE | 1.25MG | TABLET / ORAL | AB1 | 2019-01-04 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A203379-002 | GLYBURIDE | 2.5MG | TABLET / ORAL | AB1 | 2019-01-04 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A203379-003 | GLYBURIDE | 5MG | TABLET / ORAL | AB1 | 2019-01-04 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A203379-001 | GLYBURIDE | 1.25MG | TABLET / ORAL | AB1 | 2019-01-04 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A203379-002 | GLYBURIDE | 2.5MG | TABLET / ORAL | AB1 | 2019-01-04 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A203379-003 | GLYBURIDE | 5MG | TABLET / ORAL | AB1 | 2019-01-04 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A203379-001 | GLYBURIDE | 1.25MG | TABLET / ORAL | AB1 | 2019-01-04 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A203379-002 | GLYBURIDE | 2.5MG | TABLET / ORAL | AB1 | 2019-01-04 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A203379-003 | GLYBURIDE | 5MG | TABLET / ORAL | AB1 | 2019-01-04 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A203379-001 | GLYBURIDE | 1.25MG | TABLET / ORAL | AB1 | 2019-01-04 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A203379-002 | GLYBURIDE | 2.5MG | TABLET / ORAL | AB1 | 2019-01-04 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A203379-003 | GLYBURIDE | 5MG | TABLET / ORAL | AB1 | 2019-01-04 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A203379-001 | GLYBURIDE | 1.25MG | TABLET / ORAL | AB1 | 2019-01-04 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A203379-002 | GLYBURIDE | 2.5MG | TABLET / ORAL | AB1 | 2019-01-04 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A203379-003 | GLYBURIDE | 5MG | TABLET / ORAL | AB1 | 2019-01-04 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A203379-001 | GLYBURIDE | 1.25MG | TABLET / ORAL | AB1 | 2019-01-04 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A203379-002 | GLYBURIDE | 2.5MG | TABLET / ORAL | AB1 | 2019-01-04 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A203379-003 | GLYBURIDE | 5MG | TABLET / ORAL | AB1 | 2019-01-04 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A203379-001 | GLYBURIDE | 1.25MG | TABLET / ORAL | AB1 | 2019-01-04 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A203379-002 | GLYBURIDE | 2.5MG | TABLET / ORAL | AB1 | 2019-01-04 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A203379-003 | GLYBURIDE | 5MG | TABLET / ORAL | AB1 | 2019-01-04 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A203379-001 | GLYBURIDE | 1.25MG | TABLET / ORAL | AB1 | 2019-01-04 | 8072bd15b7f6… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A203379-001 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A203379-002 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A203379-003 | AB1 | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A203379-001 | AB1 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A203379-002 | AB1 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A203379-003 | AB1 | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A203379-001 | AB1 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A203379-002 | AB1 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A203379-003 | AB1 | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A203379-001 | AB1 | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A203379-002 | AB1 | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A203379-003 | AB1 | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A203379-001 | AB1 | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A203379-002 | AB1 | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A203379-003 | AB1 | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A203379-001 | AB1 | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A203379-002 | AB1 | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A203379-003 | AB1 | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A203379-001 | AB1 | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A203379-002 | AB1 | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A203379-003 | AB1 | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A203379-001 | AB1 | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A203379-002 | AB1 | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A203379-003 | AB1 | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A203379-001 | AB1 | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A203379-002 | AB1 | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A203379-003 | AB1 | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A203379-001 | AB1 | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A203379-002 | AB1 | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A203379-003 | AB1 | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A203379-001 | AB1 | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A203379-002 | AB1 | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A203379-003 | AB1 | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A203379-001 | AB1 | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A203379-002 | AB1 | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A203379-003 | AB1 | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A203379-001 | AB1 | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A203379-002 | AB1 | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A203379-003 | AB1 | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A203379-001 | AB1 | 1 | 8072bd15b7f6… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Glyburide
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| GLYBURIDE | 5 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| SX6K58TVWC | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 310537 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 51cf08e2-8a2f-4bde-996f-f431f1a68abd | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| bea938a6-c880-985b-d27b-b59b0d8b5a77 | Product name | 3 | 20170626 |
| 0600b0d3-c32a-40bb-8d87-3a2934cd8f2f | Product name | 1 | 20170616 |
| 64b2b6e2-1c04-cf4a-db4c-078ed10e1dd6 | Product name | 2 | 20160609 |
| 5a2baaae-1290-c05e-207f-b1367e9eb46a | Product name | 2 | 20151005 |
| b044018d-bcdc-e68d-63da-1ad6886aea64 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-7859-0 | Glyburide | 90 in 1 BOTTLE | TABLET | 90 | 6 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-7859-0 | EA - Each | 50090-7859 | 2e8b4140-8a87-4f91-aa6d-d7d467fdff1e | 1 | 2026-02-05 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Glyburide | GLYBURIDE | REMEDYREPACK INC. | 524eec41-37ee-419a-b7a1-d23e888ae6ab | 2026-06-12 | Warnings, Adverse reactions | 203379 ANDA203379 |
| Glyburide | GLYBURIDE | REMEDYREPACK INC. | e23b9a3b-0184-4d1c-8e2c-668697a6da87 | 2026-05-15 | Warnings, Adverse reactions | 203379 ANDA203379 |
| Glyburide | GLYBURIDE | Preferred Pharmaceuticals Inc. | cf21c8c0-7247-4d5b-97f8-ae4016144642 | 2026-05-07 | Warnings, Adverse reactions | 203379 ANDA203379 |
| Glyburide | GLYBURIDE | A-S Medication Solutions | 51cf08e2-8a2f-4bde-996f-f431f1a68abd | 2026-01-20 | Warnings, Adverse reactions | 203379 ANDA203379 50090-7859 |
| Glyburide | GLYBURIDE | NuCare Pharmaceuticals,Inc. | ffd31d06-6011-34e2-e053-6394a90a437f | 2026-01-16 | Warnings, Adverse reactions | 203379 ANDA203379 |
| Glyburide | GLYBURIDE | Bryant Ranch Prepack | db074991-1267-454a-8b1d-b6f52e2132cc | 2025-10-03 | Warnings, Adverse reactions | 203379 ANDA203379 |
| Glyburide | GLYBURIDE | A-S Medication Solutions | 676c0e45-0aa2-4060-ad18-67abb9873a50 | 2024-10-28 | Warnings, Adverse reactions | 203379 ANDA203379 |
| Glyburide | GLYBURIDE | A-S Medication Solutions | d090f978-b1a5-4db7-951d-3f32dd06966c | 2024-01-02 | Warnings, Adverse reactions | 203379 ANDA203379 |
| Glyburide | GLYBURIDE | Cadila Pharmaceuticals Limited | ea7a055b-64f0-46bf-aa8e-4a2ef5c3c035 | 2022-12-29 | Warnings, Adverse reactions | 203379 ANDA203379 |
| Glyburide | GLYBURIDE | Modavar Pharmaceuticals LLC | a5de0ef6-4c8b-40ab-b0ed-2003a8086750 | 2022-12-29 | Warnings, Adverse reactions | 203379 ANDA203379 |
| GLYBURIDE | GLYBURIDE | Nivagen Pharmaceuticals, Inc. | 43c6f68b-5747-47c6-9538-51ef8c611db4 | 2021-01-13 | Warnings, Adverse reactions | 203379 ANDA203379 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 310537 | glyBURIDE 5 MG Oral Tablet | PSN | 51cf08e2-8a2f-4bde-996f-f431f1a68abd | 6 |
| 310537 | glyburide 5 MG Oral Tablet | SCD | 51cf08e2-8a2f-4bde-996f-f431f1a68abd | 6 |
| 310537 | glibenclamide 5 MG Oral Tablet | SY | 51cf08e2-8a2f-4bde-996f-f431f1a68abd | 6 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 50090-7859-0 | 50090785900 | 90 TABLET in 1 BOTTLE (50090-7859-0) | 90 tablet | 2026-01-16 | No | No | Current |